Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. European Atherosclerosis Research Study.

The European Atherosclerosis Research Study (EARS) is a multicenter collaborative project within the European community. Its main objective is to study in young individuals the biological expression of a paternal history of premature coronary heart disease and to analyze the relative contribution of genetic and environmental factors to this expression. This study was carried out in 14 centers in 11 European countries, where the offspring of fathers who suffered a documented myocardial infarction before the age of 55 years (cases) were compared with age- and sex-matched control subjects. Plasma apolipoproteins A-I, B, A-II, A-IV, and E and lipoprotein (Lp) A-I lipoparticles were measured in this student population. Comparison of the values between cases and control subjects showed significantly higher apo B levels in cases compared with control subjects, and these differences were homogeneous throughout Europe. Regional differences were observed for apo E levels with an increasing north-south gradient, which was inversely related to that observed for triglycerides. A stepwise regression analysis including the lipid and apolipoprotein variables showed that apo B and triglycerides were the strongest discriminators between offspring of fathers with premature coronary heart disease and control subjects.

[1]  F. Cambien,et al.  The European Atherosclerosis Research Study (EARS): design and objectives. , 1994, International journal of epidemiology.

[2]  K. Widhalm Apolipoproteins in children with familial history of myocardial infarction , 1991 .

[3]  J. Fruchart,et al.  Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. , 1990, Clinical chemistry.

[4]  I. Borecki,et al.  Familial resemblance of plasma apolipoprotein B: The Nancy study , 1990, Genetic epidemiology.

[5]  J. Breslow,et al.  Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma. , 1989, Science.

[6]  G. Utermann,et al.  Quantification of human apolipoprotein A-IV by "sandwich"-type enzyme-linked immunosorbent assay. , 1988, Clinical chemistry.

[7]  M. Rosseneu,et al.  Apolipoprotein Quantitation by ELISA: Technical Aspects and Clinical Applications , 1988 .

[8]  J. Tuomilehto,et al.  Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years , 1988 .

[9]  K. Uemura,et al.  Trends in cardiovascular disease mortality in industrialized countries since 1950. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[10]  F. Cambien,et al.  Relation of parental history of early myocardial infarction to the level of apoprotein B in men. , 1987, Circulation.

[11]  T. Sveger,et al.  Hyperlipidemia in School Children with Family Histories of Premature Coronary Heart Disease , 1987, Acta paediatrica Scandinavica.

[12]  G. De Backer,et al.  Distribution and composition of HDL subclasses in students whose parents suffered prematurely from a myocardial infarction in comparison with controls. , 1987, Atherosclerosis.

[13]  B. Liu,et al.  [Quantification of human serum apolipoprotein E by enzyme-linked immunosorbent assay]. , 1987, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao.

[14]  D. Rao,et al.  Major locus inheritance of apolipoprotein B in Utah pedigrees , 1987, Genetic epidemiology.

[15]  C. Shear,et al.  The relation of apolipoproteins A-I and B in children to parental myocardial infarction. , 1986, The New England journal of medicine.

[16]  G. De Backer,et al.  Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction. , 1986, American heart journal.

[17]  R. Lauer,et al.  Lipoproteins in the progeny of young men with coronary artery disease: children with increased risk. , 1986, Pediatrics.

[18]  M. Rosseneu,et al.  Apolipoprotein E quantified by enzyme-linked immunosorbent assay. , 1986, Clinical chemistry.

[19]  M. Rosseneu,et al.  Immunonephelometry of apolipoprotein A-II in plasma. , 1984, Clinical chemistry.

[20]  J. Deslypere,et al.  Discriminative value of lipids and apoproteins in coronary heart disease. , 1982, Atherosclerosis.

[21]  D. Hosmer,et al.  A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.

[22]  C. Glueck,et al.  Identifying CHD risk factors in children: intrafamilial lipoprotein correlations. , 1980, Preventive medicine.

[23]  A. Keys,et al.  Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .

[24]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[25]  J. Goodwin,et al.  Spectrophotometry of proline in plasma and urine. , 1972, Clinical chemistry.